p53-independent apoptosis induced by muscle differentiation stimuli in polyomavirus large T-expressing myoblasts

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Gottifredi, V.
	Articles by Maione, R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Gottifredi, V.
	Articles by Maione, R.

Agah, R., Kirshenbaum, L. A., Abdellatif, M., Truong, L. D., Chakraborty, S., Michael, L. H. and Schneider, M. D (1997). Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J. Clin. Invest 100, 2722-2728.[Medline]

Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y., Bradley, A., Li. W., Bertino, J. R. and Wahl, G. M (1995). Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Nat. Acad. Sci. USA 92, 5436-5440.[Abstract/Free Full Text]

Almog, N. and Rotter, V (1997). Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta 1333, 1-27.

Bargonetti, J., Reynisdottir, I., Friedman, P. N. and Prives, C (1992). Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev 6, 1886-1898.[Abstract/Free Full Text]

Blagosklonny, M. V (1997). Loss of function and p53 protein stabilization. Oncogene 15, 1889-1893.[Medline]

Bowman, T., Symonds, H., Gu, L., Yin, C., Oren, M. and Van Dyke, T (1996). Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes Dev 10, 826-835.[Abstract/Free Full Text]

Brezden, C. B. and Rauth, A. M (1996). Differential cell death in immortalized and non-immortalized cells at confluency. Oncogene 12, 201-206.[Medline]

Chiou, S. K. and White, E (1997). p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol 71, 3515-3525.[Abstract]

Debbas, M. and White, E (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 7, 546-554.[Abstract/Free Full Text]

Demers, G. W., Halbert, C. L. and Galloway, D. A (1994). Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198, 169-174.[Medline]

Deppert, W., Haug, M. and Steinmayer, T (1987). Modulation of p53 protein expression during cellular transformation with simian virus 40. Mol. Cell. Biol 7, 4453-4463.[Abstract/Free Full Text]

Doherty, J. and Freund, R (1997). Polyomavirus large T antigen overcomes p53 dependent growth arrest. Oncogene 14, 1923-1931.[Medline]

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A. Jr., Butel, J. S. and Bradley, A (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.[Medline]

Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z. and Hancock, D. C (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.[Medline]

Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R. and Prives, C (1992). Wild-type p53 activates transcription in vitro [see Comments]. Nature 358, 83-86.[Medline]

Fimia, G. M., Gottifredi, V., Bellei, B., Ricciardi, M. R., Tafuri, A., Amati, P. and Maione, R (1998). The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts. Mol. Biol. Cell 9, 1449-1463.[Abstract/Free Full Text]

Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol 119, 493-501.[Abstract/Free Full Text]

Gorman, C. M., Moffat, L. F. and Howard, B. H (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol 2, 1044-1051.[Abstract/Free Full Text]

Gottlieb, E., Haffner, R., von Ruden, T., Wagner, E. F. and Oren, M (1994). Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J 13, 1368-1374.[Medline]

Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W. and Giaccia, A. J (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours [see Comments]. Nature 379, 88-91.[Medline]

Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. K. and Israel, M. A (1995). Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 14, 461-472.[Medline]

Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D. and Lassar, A. B (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD [see Comments]. Science 267, 1018-1021.[Abstract/Free Full Text]

Hansen, R. and Oren, M (1997). p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev 7, 46-51.[Medline]

Haupt, Y., Rowan, S. and Oren, M (1995). p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10, 1563-1571.[Medline]

Hermeking, H. and Eick, D (1994). Mediation of c-Myc-induced apoptosis by p53. Science 265, 2091-2093.[Abstract/Free Full Text]

Hiebert, S. W., Packham, G., Strom, D. K., Haffner, R., Oren, M., Zambetti, G. and Cleveland, J. L (1995). E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol 15, 6864-6874.[Abstract]

Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G., Albert, D. M. and Windle, J. J (1994). Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53 [published erratum appears in Genes Dev._Fb_8 , 1738]. Genes Dev 8, 1300-1310.[Abstract/Free Full Text]

Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K. and Lu, X (1997). E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 11, 1840-1852.[Abstract/Free Full Text]

Jiang, D., Srinivasan, A., Lozano, G. and Robbins, P. D (1993). SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene 8, 2805-2812.[Medline]

Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W. and Vogelstein, B (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827-830.[Abstract/Free Full Text]

King, K. L. and Cidlowski, J. A (1995). Cell cycle and apoptosis: common pathways to life and death. J. Cell Biochem 58, 175-180.[Medline]

Ko, L. J. and Prives, C (1996). p53: puzzle and paradigm. Genes Dev 10, 1054-1072.[Free Full Text]

Kowalik, T. F., DeGregori, J., Schwarz, J. K. and Nevins, J. R (1995). E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol 69, 2491-2500.[Abstract]

Lee, E. Y., Hu, N., Yuan, S. S., Cox, L. A., Bradley, A., Lee, W. H. and Herrup, K (1994). Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 8, 2008-2021.[Abstract/Free Full Text]

Levine, A. J (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.[Medline]

Lowe, S. W. and Ruley, H. E (1993). Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7, 535-545.[Abstract/Free Full Text]

Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967.[Medline]

Lowe, S. W., Jacks, T., Housman, D. E. and Ruley, H. E (1994). Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Nat. Acad. Sci. USA 91, 2026-2030.[Abstract/Free Full Text]

Maione, R., Fimia, G. M., Holman, P., Schaffhausen, B. and Amati, P (1994). Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell Growth Differ 5, 231-237.[Abstract]

Maione, R. and Amati, P (1997). Interdependence between muscle differentiation and cell-cycle control. Biochim. Biophys. Acta 1332, 19-.

Manfredi, J. J. and Prives, C (1990). Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen. J. Virol 64, 5250-5259.[Abstract/Free Full Text]

Miyashita, T. and Reed, J. C (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.[Medline]

Morgenbesser, S. D., Williams, B. O., Jacks, T. and DePinho, R. A (1994). p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens [see Comments]. Nature 371, 72-74.[Medline]

Morgenstern, J. P. and Land, H (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucl. Acids Res 18, 3587-3596.[Abstract/Free Full Text]

Packham, G., Porter, C. W. and Cleveland, J. L (1996). c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13, 461-469.[Medline]

Pan, H. and Griep, A. E (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 8, 1285-1299.[Abstract/Free Full Text]

Park, D. S., Farinelli, S. E. and Greene, L. A (1996). Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem 271, 8161-8169.[Abstract/Free Full Text]

Pear, W. S., Nolan, G. P., Scott, M. L. and Baltimore, D (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Nat. Acad. Sci. USA 90, 8392-8396.[Abstract/Free Full Text]

Phillips, A. C., Bates, S., Ryan, K. M., Helin, K. and Vousden, K. H (1997). Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev 11, 1853-1863.[Abstract/Free Full Text]

Qin, X. Q., Livingston, D. M., Kaelin, W. G. Jr and Adams, P. D (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Nat. Acad. Sci. USA 91, 10918-10922.[Abstract/Free Full Text]

Querido, E., Teodoro, J. G. and Branton, P. E (1997). Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J. Virol 71, 3526-3533.[Abstract]

Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Muller, R., Ansorge, W. and Eilers, M (1996). Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J 15, 3065-3076.[Medline]

Sastry, S. K., Lakonishok, M., Thomas, D. A., Muschler, J. and Horwitz, A. F (1996). Integrin alpha subunit ratios, cytoplasmic domains, and growth factor synergy regulate muscle proliferation and differentiation. J. Cell Biol 133, 169-184.[Abstract/Free Full Text]

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. and Lowe, S. W (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.[Medline]

Shan, B. and Lee, W. H (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol 14, 8166-8173.[Abstract/Free Full Text]

Shaulian, E., Zauberman, A., Ginsberg, D. and Oren, M (1992). Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol 12, 5581-5592.[Abstract/Free Full Text]

Sherr, C. J (1998). Tumor surveillance via the ARF-p53 pathway [In Process Citation]. Genes Dev 12, 2984-2991.[Free Full Text]

Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M. G., Bossi, G., Cimino, L., Crescenzi, M. and Sacchi, A (1996). Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol 134, 193-204.[Abstract/Free Full Text]

Somasundaram, K. and El-Deiry, W. S (1997). Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047-1057.[Medline]

Steegenga, W. T., van Laar, T., Riteco, N., Mandarino, A., Shvarts, A., van der Eb, A. J. and Jochemsen, A. G (1996). Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell. Biol 16, 2101-2109.[Abstract]

Tamir, Y. and Bengal, E (1998). p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene. Oncogene 17, 347-356.[Medline]

Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L. and Jacks, T (1998). Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survivals of Rb-deficient mouse embryos. Mol. Cell 2, 293-304.

Wagner, A. J., Kokontis, J. M. and Hay, N (1994). Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 8, 2817-2830.[Abstract/Free Full Text]

Wang, J. and Walsh, K (1996). Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359-361.[Abstract]

Wang, J., Guo, K., Wills, K. N. and Walsh, K (1997). Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res 57, 351-354.[Abstract/Free Full Text]

Weintraub, H., Tapscott, S. J., Davis, R. L., Thayer, M. J., Adam, M. A., Lassar, A. B. and Miller, A. D (1989). Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Nat. Acad. Sci. USA 86, 5434-5438.[Abstract/Free Full Text]

White, E., Cipriani, R., Sabbatini, P. and Denton, A (1991). Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol 65, 2968-2978.[Abstract/Free Full Text]

White, E (1994). Tumour biology. p53, guardian of Rb [news; comment]. Nature 371, 21-22.[Medline]

Wright, W. E., Binder, M. and Funk, W (1991). Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell Biol 11, 4104-4110.[Abstract/Free Full Text]

Wu, X. and Levine, A. J (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc. Nat. Acad. Sci. USA 91, 3602-3606.[Abstract/Free Full Text]

Yaffe, D. and Saxel, O (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.[Medline]

Zacksenhaus, E., Jiang, Z., Chung, D., Marth, J. D., Phillips, R. A. and Gallie, B. L (1996). pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 10, 3051-3064.[Abstract/Free Full Text]

This article has been cited by other articles:

F. M. Yakes, B. D. Wamil, F. Sun, H.-P. Yan, C. E. Carter, and C. G. Hellerqvist
CM101 Treatment Overrides Tumor-induced Immunoprivilege Leading to Apoptosis
Cancer Res., October 1, 2000; 60(20): 5740 - 5746.
[Abstract] [Full Text]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Gottifredi, V.

Articles by Maione, R.

Search for Related Content

PubMed

PubMed Citation

Articles by Gottifredi, V.

Articles by Maione, R.